Overcoming cancer therapeutic bottleneck by drug repurposing
Ever present hurdles for the discovery of new drugs for cancer therapy have necessitated
the development of the alternative strategy of drug repurposing, the development of old …
the development of the alternative strategy of drug repurposing, the development of old …
The Multifaceted p21 (Cip1/Waf1/CDKN1A) in Cell Differentiation, Migration and Cancer Therapy
NN Kreis, F Louwen, J Yuan - Cancers, 2019 - mdpi.com
Loss of cell cycle control is characteristic of tumorigenesis. The protein p21 is the founding
member of cyclin-dependent kinase inhibitors and an important versatile cell cycle protein …
member of cyclin-dependent kinase inhibitors and an important versatile cell cycle protein …
Targeting autophagy using natural compounds for cancer prevention and therapy
S Deng, MK Shanmugam, AP Kumar, CT Yap, G Sethi… - Cancer, 2019 - Wiley Online Library
Autophagy, also known as macroautophagy, is a tightly regulated process involved in the
stress responses, such as starvation. It is a vacuolar, lysosomal pathway for the degradation …
stress responses, such as starvation. It is a vacuolar, lysosomal pathway for the degradation …
Targeting tumor hypoxia and mitochondrial metabolism with anti-parasitic drugs to improve radiation response in high-grade gliomas
Abstract High-grade gliomas (HGGs), including glioblastoma and diffuse intrinsic pontine
glioma, are amongst the most fatal brain tumors. These tumors are associated with a dismal …
glioma, are amongst the most fatal brain tumors. These tumors are associated with a dismal …
[HTML][HTML] Selective autophagy regulates cell cycle in cancer therapy
K Zheng, Z He, K Kitazato, Y Wang - Theranostics, 2019 - ncbi.nlm.nih.gov
Aberrant function of cell cycle regulators results in uncontrolled cell proliferation, making
them attractive therapeutic targets in cancer treatment. Indeed, survival of many cancers …
them attractive therapeutic targets in cancer treatment. Indeed, survival of many cancers …
The p53/p21 complex regulates cancer cell invasion and apoptosis by targeting Bcl-2 family proteins
EM Kim, CH Jung, J Kim, SG Hwang, JK Park, HD Um - Cancer research, 2017 - AACR
The tumor suppressor p53 binds prosurvival Bcl-2 family proteins such as Bcl-w and Bcl-XL
to liberate Bax, which in turn exerts proapoptotic or anti-invasive functions depending on …
to liberate Bax, which in turn exerts proapoptotic or anti-invasive functions depending on …
Autophagy: a druggable process
E Morel, M Mehrpour, J Botti, N Dupont… - Annual Review of …, 2017 - annualreviews.org
Macroautophagy (hereafter called autophagy) is a vacuolar, lysosomal pathway for
catabolism of intracellular material that is conserved among eukaryotic cells. Autophagy …
catabolism of intracellular material that is conserved among eukaryotic cells. Autophagy …
Recent advance of herbal medicines in cancer-a molecular approach
Bioactive compounds are crucial for an extensive range of therapeutic uses, and some
exhibit anticancer activity. Scientists advocate that phytochemicals modulate autophagy and …
exhibit anticancer activity. Scientists advocate that phytochemicals modulate autophagy and …
Phytochemicals as a complement to cancer chemotherapy: pharmacological modulation of the autophagy-apoptosis pathway
Bioactive plant derived compounds are important for a wide range of therapeutic
applications, and some display promising anticancer properties. Further evidence suggests …
applications, and some display promising anticancer properties. Further evidence suggests …
Repurposing quinacrine for treatment-refractory cancer
Quinacrine, also known as mepacrine, has originally been used as an antimalarial drug for
close to a century, but was recently rediscovered as an anticancer agent. The mechanisms …
close to a century, but was recently rediscovered as an anticancer agent. The mechanisms …